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Abstract
Background:  The c-Cbl-associated protein (CAP), also known as ponsin, localizes to focal
adhesions and stress fibers and is involved in signaling events. Phosphorylation has been described
for the other two members of the sorbin homology family, vinexin and ArgBP2, but no data exist
about the putative phosphorylation of CAP. According to previous findings, CAP binds to tyrosine
kinase c-Abl. However, it is not known if CAP is a substrate of c-Abl or other tyrosine kinases or
if phosphorylation regulates its localization.
Results: We here show that CAP is Tyr phosphorylated by and interacts with both c-Abl and c-
Src. One major phosphorylation site, Tyr360, and two minor contributors Tyr326 and Tyr632
were identified as Abl phosphorylation sites, whereas Src preferentially phosphorylates Tyr326 and
Tyr360. Phosphorylation of CAP was not necessary for its localization to focal adhesions and stress
fibers, but Tyr326Phe substitution alters the function of CAP during cell spreading.
Conclusion: This is the first demonstration of phosphorylation of CAP by any kinase. Our findings
suggest that coordinated action of Src and Abl might regulate the function of CAP and reveal a
functional role especially for the Src-mediated Tyr phosphorylation of CAP in cell spreading.
Background
CAP (c-Cbl-associated protein), also known as ponsin [1],
is an adaptor protein which has been associated with reg-
ulation of the actin cytoskeleton, signaling through recep-
tor tyrosine kinases and cell adhesion [2]. Numerous
isoforms of CAP with different tissue distributions have
been described in the literature, although their specific
functions remain to be clarified [1,3-6]. Consistent with
the function of CAP as an adaptor protein, most of these
isoforms show a predominant localization with actin
cytoskeleton, stress fibers, focal adhesions or cell-cell
adhesion structures [7,8], but an isoform containing a
nuclear localization signal has also been described [3].
CAP belongs to the so-called Sorbin homology (SoHo)
protein family [2] together with vinexin-α and Arg-bind-
ing protein 2 (ArgBP2). All three members of this family
contain in their N-terminal part one SoHo domain which
was named after its homology to the gut peptide sorbin
that participates in the regulation of absorption of water
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and electrolytes in the gall bladder [9]. However, the exact
molecular function of the SoHo domain has only recently
been elucidated. The SoHo domain of CAP was shown to
be necessary for the formation of molecular complexes
with the membrane raft-associated protein flotillin-1/reg-
gie-2 (Flot-1) during insulin receptor signaling [10]. Upon
insulin stimulation, CAP and c-Cbl are recruited by APS
(Adapter Protein with pleckstrin homology and Src
homology 2 domains) to insulin receptor [11], and c-Cbl
becomes Tyr-phosphorylated. The CAP-c-Cbl complexes
are then recruited to rafts by means of an interaction of the
SoHo domain of CAP with Flot-1, which results in specific
signaling events within raft membranes [10]. Later find-
ings have suggested that a similar complex containing
CAP/c-Cbl/Flot-1 would also play a role during signaling
mediated by neurotrophic factor receptor TrkA [12]. In
addition, other SoHo proteins have also been suggested to
form SoHo-mediated signaling complexes with Flot-1
[13,14].
In addition to the SoHo domain, a characteristic feature of
all these family members is the presence of three SH3
domains (referred to as SH3-A, -B and -C) in the C-termi-
nal part of the protein [2]. SH3 domains are well known
protein-protein interaction motifs that bind to proline-
rich sequences and facilitate the formation of molecular
complexes with various ligands [15]. The SH3 domains B
and C of CAP/Ponsin have been shown to mediate the
interaction with afadin which in turn is a binding partner
of the transmembrane protein nectin in cell-cell adhesion
structures that precede the formation of cadherin-based
adherens junctions in epithelial cells [1,16]. The third
SH3 domain of CAP also binds to c-Cbl, and focal adhe-
sion kinase (FAK) has been reported to bind to SH3-B
[5,7]. All three SoHo proteins directly interact with the
actin associated protein vinculin [1,17-19], the localiza-
tion of which largely overlaps that of the SoHo proteins in
cell-matrix adhesions and stress fibers. The interaction
with vinculin is mediated by the SH3 domains A and B in
CAP [1].
In agreement with their role as cytoskeletal adaptor pro-
teins, CAP, vinexin and ArgBP2 have been shown to be
strongly associated with actin cytoskeleton and focal
adhesions. Tyrosine phosphorylation of vinexin-α and
ArgBP2 by c-Abl tyrosine kinase has previously been
reported [20,21]. In both cases, the SH3 domains, espe-
cially SH3-C, were found to be important for this interac-
tion. CAP has also been reported to bind to and
coimmunoprecipitate with c-Abl in insulin stimulated
hepatocytic cell line Hep3B, and in vitro experiments
indicated that SH3-C in CAP would be a binding determi-
nant of c-Abl [4]. However, no data are available if CAP is
also phosphorylated by c-Abl and how the putative phos-
phorylation regulates the function of CAP. In addition,
the possibility that CAP might be phosphorylated by
other Tyr kinases known to be important for the regula-
tion of the actin cytoskeleton and cell adhesions, such as
the Src family kinases, remains to be investigated.
Here we show that CAP is indeed Tyr phosphorylated by
both c-Abl and c-Src, and CAP can be coimmunoprecipi-
ated with active forms of the kinases. The SH3 domains of
CAP participate in the interaction in vivo but appear not
to be the only binding determinants of c-Abl in CAP. We
have identified Tyr360 in CAP as the primary phosphor-
ylation site of c-Abl. In addition, Tyr632 appears to con-
tribute to the phosphorylation of CAP by Abl, whereas Src
phosphorylates both Tyr326 and Tyr360. Interestingly,
mutation of Tyr326 altered the function of CAP during
cell spreading, whereas exchange of Tyr360 or Tyr632 did
not influence the spreading. However, none of the muta-
tions affected the localization of CAP in focal adhesions
or stress fibers.
Results
CAP is Tyr phosphorylated in vanadate treated Hep3B 
cells
A previous report showed that CAP coimmunoprecipi-
tates with c-Abl from insulin stimulated Hep3B cells [4].
To study if CAP is also phosphorylated in these cells, we
immunoprecipitated endogenous CAP from cells stimu-
lated with insulin or treated with vanadate. A signal for
Tyr phosphorylated CAP was detected in vanadate-treated
cells, whereas nonstimulated or insulin-treated cells
showed no signal (Figure 1A). Several isoforms of CAP
were expressed in Hep3B cells, but mainly the 150 kDa
isoform was found to be Tyr phosphorylated.
CAP is phosphorylated by and interacts with c-Abl
Since Hep3B cells are extremely difficult to transfect and
endogenously contain several isoforms of CAP, we chose
HeLa cells for further experiments since they do not
express any endogenous CAP [8]. For this, we used over-
expression of N-terminally GFP-tagged isoform CAP1
(GenBank: U58883) which contains a SoHo domain and
three SH3 domains C-terminally to it (Figure 1B). Coim-
munoprecipitation of various activity mutants of c-Abl
(WT: wild-type, Abl KD: kinase-dead, Abl PP: constitu-
tively active) with CAP-EGFP was analyzed. Abl WT and
PP were found to coimmunoprecipitate with CAP,
whereas the Abl KD was not (Figure 1C). Although the
expression of Abl PP was low in cell lysates (lowermost
panel) due to toxicity of high level expression, a similar
amount to Abl WT was detected in immunoprecipitates,
indicating that a higher percentage of the cellular Abl PP
was associated with CAP.
It has been reported that the third SH3 domain (SH3-C)
of CAP binds Abl in vitro. We thus used CAP mutants car-BMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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rying mutations or deletions in the SH3 domain region
(Figure 1B) to study the coimmunoprecipitation of WT
Abl. Although the full-length CAP coprecipitated Abl, the
C-terminal deletion mutant of CAP, ΔSH3, missing all
three SH3 domains, did not precipitate any Abl (Figure
1D). However, point mutants W660F, carrying a WF sub-
stitution in the absolutely conserved, critical Trp residue
in SH3-C, and the mutant 3 × WF, in which all three SH3
domains of CAP have been mutated, both were capable of
coprecipitating reduced but still considerable amounts of
Abl.
We next studied if CAP would be tyrosine phosphorylated
by c-Abl. Upon coexpression of Abl WT and PP, a high
degree of Tyr phosphorylation of CAP was detected,
whereas no phosphorylation was deteted in cells cotrans-
fected with Abl KD (Figure 2A). The phosphorylation of
CAP upon coexpression of Abl PP was higher than with
CAP is phosphorylated by and coimmunoprecipitates with c-Abl Figure 1
CAP is phosphorylated by and coimmunoprecipitates with c-Abl. A: Hep3B cells were starved, treated with insulin or 
vanadate, and CAP was immunoprecipitated with specific antibodies. Tyr phosphorylation of CAP was analyzed by Western 
blot. Endogenous CAP was phosphorylated after vanadate treatment but not in starved cells or after insulin stimulation. B: 
Schematic presentation of the CAP constructs based on the isoform CAP1 used in this study. See text for details. C: HeLa cells 
were cotransfected with CAP-EGFP or EGFP and either c-Abl WT, kinase-dead mutant (Abl KD) or constitutively active Abl 
(Abl PP). CAP was immunoprecipitated with GFP antibodies and coprecipitation of Abl was detected by means of Western 
blot (uppermost panel). Abl WT and PP were coprecipitated with CAP whereas Abl KD was not. D: Coprecipitation of Abl 
WT with various mutants of CAP. Abl WT was found to coprecipitate with full-length CAP, and somewhat less with the third 
SH3 domain mutant W660F and the 3 × WF mutant in which all three SH3 domains of CAP have been mutated. No coprecip-
itation was observed with CAPΔSH3 or EGFP only.BMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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Abl WT, despite the fact that the expression level of Abl PP
was much lower than that of Abl WT.
Having established that CAP is a substrate of Abl kinase,
we studied the phosphorylation of CAP mutants contain-
ing substitutions in the SH3 domain region (Figure 2B).
Consistent with its inability to bind to Abl, CAP ΔSH3 was
phosphorylated very little upon Abl coexpression. How-
ever, the WF point mutants containing substitutions
either in one of the SH3 domains (W480F: SH3-A,
W554F: SH3-B, W660F: SH3-C) or in all three SH3
domains (3xWF) showed a phosphorylation comparable
to or even higher than WT CAP, again consistent with
their ability to associate with Abl. These results would sug-
gest that although functional SH3 domains are not neces-
sary for the tyrosine phosphorylation of CAP by c-Abl, the
C-terminal part of CAP is required for a productive inter-
action.
We then sought to identify the Tyr residues in CAP that
would be phosphorylated by Abl. It has been shown that
Abl preferably phosphorylates substrates with the consen-
sus sequence I/L/V-Y-(X)1-5-P/F around the Tyr residue to
be phosphorylated [22]. Such a sequence was found
around three Tyr in CAP, namely Y326, Y360 and Y632,
which were mutated into Phe residues. Phosphorylation
of CAP upon coexpression of Abl was again analyzed (Fig-
ure 3). No phosphorylation signal was detected in cells
transfected with CAP alone or with Abl and EGFP. The
mutant Y326F was found to be phosphorylated at about
equal level as the WT CAP, and Y632F showed a moderate
reduction of phosphorylation (55% ± 17% of WT level).
However, Y360F mutant showed a clearly reduced phos-
phorylation (19% ± 8.0%). Interestingly, the double
mutants Y326F+Y360F (33% ± 26%) and Y360F+Y632F
(12% ± 11%) both exhibited a low degree of phosphor-
ylation. These data suggest that Y360 is the main phos-
phorylation site, but Y632 also seems to contribute to the
phosphorylation of CAP by Abl.
Mutation of Tyr 326, 360 or 632 does not affect the 
localization of CAP into focal adhesions and stress fibers
CAP has been reported to localize in stress fibers and to
colocalize with vinculin in focal adhesions [1]. When WT
CAP transfected cells were seeded out on fibronectin and
allowed to spread (Figure 4, upper panel), after 30 min we
observed a localization of CAP (green) in focal adhesions
at the cell periphery where it colocalized with vinculin
(blue) but only poorly with cortical actin fibers (red).
After the cells had spread out for 120 min (Figure 4, lower
panel), a minor fraction of CAP colocalized with vinculin
(blue) in focal adhesions, whereas most of the CAP pro-
tein was detected in stress fibers, colocalizing with actin
(red). We could not detect any clear difference in the
Kinase activity of Abl is necessary for the phosphorylation of CAP Figure 2
Kinase activity of Abl is necessary for the phosphorylation of CAP. HeLa cells were cotransfected with WT and 
mutants of CAP-EGFP and Abl. CAP was immunoprecipitated with GFP antibodies and the phosphorylation status was 
detected with anti-phospho-Tyr antibodies in Western blots. A: Full-length CAP was phosphorylated by Abl WT and Abl PP 
but not by Abl KD. B: WT CAP, all single WF and the 3xWF SH3 domain mutants were phosphorylated upon coexpression of 
c-Abl, whereas the CAPΔSH3 mutant was not.BMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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Y360 in CAP is the major phosphorylation site of c-Abl Figure 3
Y360 in CAP is the major phosphorylation site of c-Abl. A: Tyr residues 326, 360 and 632 in CAP were mutated into 
Phe and their phosphorylation upon c-Abl coexpression was analyzed as in Figure 2. No phosphorylation of CAP was detected 
in the absence of coexpressed Abl kinase. Y360F, Y632F, Y326F+Y360F and Y360+Y632F exhibited a reduced Tyr phosphor-
ylation whereas Y326F was comparable to WT CAP. B: Quantitative analysis of the phosphorylation summarizing data from 
three experiments. The phosphorylation signals were normalized with the expression level of the respective variants and given 
as % of WT CAP phosphorylation. Error bars show standard deviation.BMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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Tyrosine mutations do not alter the localization of CAP into focal adhesions and stress fibers Figure 4
Tyrosine mutations do not alter the localization of CAP into focal adhesions and stress fibers. Cells transfected 
with CAP-EGFP, Y326F, Y360F or Y632F mutant were seeded out on fibronectin coated coverslips, allowed to adhere for 30 
min or 120 min, fixed and stained for vinculin (blue) and phalloidin (red). WT CAP, Y326F and Y360F mutant were found to 
show a similar overall localization, whereas Y632F mutant exhibited some nuclear staining, in addition to focal adhesions and 
stress fibers. All CAP variants showed two localization patterns, either colocalizing with vinculin in cell matrix adhesions after 
shorter spreading times (30 min) or with actin fibers after longer times of spreading (120 min).BMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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localization of the Y326F, Y360F (Figure 4) or
Y326F+Y360F mutant (not shown) as compared to the
WT CAP. However, mutant Y632F was localized both in
focal adhesions and stress fibers (Figure 4) but addition-
ally showed some nuclear localization. These results
imply that Abl mediated phosphorylation is not necessary
for association of CAP with focal adhesions or stress fib-
ers. However, during the spreading of the cells, the locali-
zation of CAP seems to dynamically change from focal
adhesions to stress fibers, according to the spreading state
of the cells.
Y326F mutant exhibits an inhibitory effect on cell 
spreading
Although the localizations of CAP and the Tyr mutants
were similar during various time points of cell spreading
(Figure 4), these data provide only limited information
on the role of phosphorylation during active, dynamic cell
spreading. In order to study the possible functional role of
the Tyr phosphorylation, we performed spreading assays
of transfected HeLa cells on a fibronectin matrix (Figure
5). In this assay, the cells were allowed to spread on
fibronectin coated surface for 25 min, fixed and scored for
their spreading state in three categories (non-spread for
round cells that were barely attached; half-spread for cells
that showed filopodia and had begun to flatten; spread for
flat cells with well-spread lamellipodia). The cells trans-
fected with EGFP, WT CAP, Y360F and Y632F mutant all
showed a high degree (70-80%) of fully spread cells.
However, in the case of the Y326F mutant, a clearly inhib-
itory effect on the spreading of the cells was detected, with
only 40% of the cells exhibiting a fully spread phenotype
and some 45% showing a half-spread morphology with
many filopodia-like protrusions. Thus, mutation of
Tyr326 in CAP appears to have an inhibitory effect on cell
spreading.
CAP is phosphorylated by c-Src
Since Tyr326 was not a major c-Abl phosphorylation site,
we sought to identify a putative other kinase that might be
involved in the phosphorylation of Y326 in CAP. Src
kinases are good candidates for this since they have been
shown to play an important role not only in signal trans-
duction by growth factors but also in the regulation of cell
Y326F substitution in CAP impairs cell spreading on fibronectin Figure 5
Y326F substitution in CAP impairs cell spreading on fibronectin. HeLa cells transfected with various CAP-EGFP con-
structs were allowed to adhere to fibronectin-coated coverslips for 25 min, then washed and fixed. The cells were scored on 
the basis of their spreading status as non-spread, half-spread or fully spread. WT CAP, Y360F or Y632F mutant showed no 
effect on cell spreading as compared to EGFP transfected cells, whereas Y326F mutant exhibited a slower spreading rate. The 
graph shows the results of 3 independent experiments with at least 100 cells scored in each. Error bars = SD.BMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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matrix adhesion. Recombinant Src kinase was indeed
capable of phosphorylating the purified CAP-GST protein
in an in vitro phosphorylation assay, whereas inhibition of
Src activity by means of PP2 completely abrogated CAP
phosphorylation in the in vitro assay (Fig 6A) and severely
impaired it in transfected cells (Figure 6B). When cells
were transfected with CAP-EGFP and Src kinase constructs
(c-Src: WT Src, Y527F: constitutively active Src, Dead-Src:
kinase-inactive Src), an increased phosphorylation of CAP
variants was detected, correlating with the activity level of
Src (Figure 6C). The small amount of phosphorylated
CAP detected in cells transfected with Dead-Src is most
likely due to phosphorylation by endogenous c-Src and
enhancement upon vanadate incubation. As with c-Abl,
phosphorylation of CAP by c-Src appears not to depend
on functional SH3 domains since the SH3 domain
mutants of CAP were found to be Tyr phosphorylated to a
comparable level as the WT CAP (Figure 6D and not
shown for W480F and W554F). As with the Abl kinase,
only active forms of Src were found to coprecipitate with
CAP, and deletion of the SH3 region of CAP resulted in
severely reduced coprecipitation of Src with CAP (Figure
6E).
To corroborate these findings, mouse embryonal fibrob-
lasts genetically ablated for the ubiquitous Src kinases Src,
Yes and Fyn (SYF cells) [23,24] were transfected with CAP-
EGFP. In these cells, no phosphorylation of CAP-EGFP
could be detected. However, phosphorylation of CAP
could be rescued upon coexpression of WT and constitu-
tively active Src, but not of the kinase dead Src. (Figure 7).
In order to identify the residues phosphorylated by Src,
CAP-EGFP and its Tyr-mutated forms were coexpressed
with c-Src in HeLa cells (Figure 8A). Substitution of Y326
or Y360, which represents the main phosphorylation site
of c-Abl, alone only moderately impaired the phosphor-
ylation of CAP by Src. However, the double mutant
Y326+360F showed a clearly reduced level of Tyr phos-
phorylation, indicating that tyrosines 326 and 360 both
might be phosphorylation sites of Src in CAP. Substitu-
tion Y632F showed no effect on the phosphorylation of
CAP by Src (data not shown).
Since Y360 is also the major phosphorylation site of Abl
in CAP, c-Src and c-Abl kinases could cooperate for the
phosphorylation of CAP. To test this, CAP-EGFP was
cotransfected with either c-Abl or c-Src, and the cells were
treated with the Src inhibitor PP2 or a non-inhibitory con-
trol compound PP3. PP2 was used since, in contrast to
PP1 and many other Src inhibitors, it does not inhibit Abl
kinase activity in the concentration used here. Inhibition
of Src activity in c-Abl transfected cells resulted in a reduc-
tion of CAP phosphorylation, whereas in Src transfected
cells, no phosphorylation of CAP could be detected upon
use of PP2. These results would imply that there is some
cooperativity of CAP phosphorylation between c-Src and
c-Abl.
Discussion
We have here shown that endogenously expressed CAP
can be Tyr phosphorylated in Hep3B hepatocytes,
whereas previous findings from others have demonstrated
that in these cells, CAP can be coimmunoprecipitated
with c-Abl kinase [4]. Although other members of the
SoHo protein family have been shown to be phosphor-
ylated by c-Abl [20,21], our report is the first demonstra-
tion of Tyr phosphorylation of CAP by any kinase. CAP
has been shown to play a role in membrane receptor sig-
nal transduction, e.g. insulin and neurotrophic factor sig-
naling [10,12]. We were not able to detect phosphorylated
CAP in insulin treated Hep3B cells, whereas vanadate
stimulation resulted in robust Tyr phosphorylation of
CAP. This might indicate that the phosphorylation of CAP
during signaling is regulated by rapid dephosphorylation
by phosphatases, and thus phosphorylation can only be
detected upon inhibition of phosphatase activity by vana-
date. It will be of interest to determine if CAP is phospho-
rylated in other cell types during signaling processes, and
if so, which kinases and phosphatases mediate the phos-
phorylation and dephosphorylation.
The third SH3 domain of CAP (SH3-C) has previously
been shown to bind to c-Abl in vitro [4]. According to our
results, the delta-SH3 mutant of CAP missing all three
SH3 domains was neither capable of coprecipitating c-Abl
nor phosphorylated by it. However, we observed only a
slightly reduced coprecipitation of c-Abl with the mutants
in which either SH3-C or all three SH3 domains of CAP
were mutated. As the Trp substitutions render SH3
domains incapable of binding their poly-Pro containing
recognition signals, these results would suggest that
although the binding site of Abl in CAP is located in the
C-terminal part containing the SH3 domains, there have
to be determinants other than the SH3 domains, e.g. the
linker regions in between, which are important for the
interaction of Abl with CAP. Interestingly, the linker
region between SH3-B and -C contains a putative Pro-rich
sequence (PQQP) which might function as a binding site
for the SH3 domain of c-Abl, thus facilitating a dual inter-
action mediated by SH3 domains/Pro-rich regions in both
proteins. A similar binding mode has also been impli-
cated between vinexin and c-Abl [20]. However, mutation
of the PQQP motif into AEEA did not significantly reduce
the phosphorylation of CAP in the presence of intact SH3
domains (data not shown). Although this would rather
speak against the role of the PQQP motif in the binding
of Abl, an interaction mediated by more than one deter-
minant would also be supported by the fact that the con-
stitutively active Abl-PP mutant coprecipitated with CAPBMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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CAP is a substrate of Src kinase Figure 6
CAP is a substrate of Src kinase. A: Purified CAP-GST or GST was incubated with recombinant, purified Src kinase and [γ-
32P]-ATP, run into SDS-PAGE gel and analyzed by autoradiography. Specific phosphorylation of CAP-GST could be detected 
after incubation with active Src but not after inhibition of Src activity with PP2. Autophosphorylation of Src was used as an 
internal control for successful inhibition. B: CAP-EGFP or EGFP were immunoprecipitated from cells treated with vanadate and 
either Src inhibitors PP1 or PP2 or a non-inhibiting analogue PP3. Inhibition of endogenous Src activity clearly reduced the Tyr 
phosphorylation of CAP-EGFP. C: Coexpression of active forms of Src kinase (c-Src or Y527F-Src) notably increased the Tyr-
phosphorylation of CAP-EGFP as compared to cells coexpressing the inactive Src mutant (Dead-Src). D: Intact SH3 domains of 
CAP are not necessary for the phosphorylation of CAP by Src. CAP-EGFP or CAP mutants carrying mutations in the SH3 
domains were coexpressed and the phosphorylation of CAP was studied after immunoprecipitation. Mutation of the critical 
tryptophane in the third SH3 domain (W660F-CAP-EGFP) or in all three SH3 domains (3xWF-CAP-EGFP) exhibited no effect 
on the degree of Tyr phosphorylation of CAP by Src. E: Active forms of Src (c-Src and Y527F-Src) were coprecipitated with 
WT CAP and to a severely reduced degree with the ΔSH3 mutant of CAP, whereas kinase dead Src did not associate with 
either the WT or ΔSH3 CAP.BMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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more than c-Abl. In Abl-PP, two Pro residues in the linker
region between the SH2 and kinase domain have been
mutated so that the protein acquires an open conforma-
tion [25] and might be able to bind more efficiently to its
substrate, CAP. On the other hand, since phosphorylation
of CAP was readily observed in cells coexpressing WT Abl
and CAP, this might imply that binding of CAP to c-Abl
could even increase the activity of the kinase which is
under tight regulation in normal cells (see [26] for
review). However, further experiments will be required to
clarify the exact binding mechanism between CAP and
Abl.
We have here identified Tyr360 in CAP as a major phos-
phorylation site by c-Abl, although Tyr 632 also might
contribute since its substitution in combination with the
Y360F mutation reduced the phosphorylation of CAP to a
very low level. Both Tyr conform to the consensus c-Abl
phosphorylation motif. Interestingly, in mouse vinexin,
the major phosphorylation site of c-Abl is provided by
Y127 with some possible contribution by Y269 and Y394
[20]. However, different from Y360 in CAP, Tyr127 of vin-
exin does not seem to reside in a consensus phosphoryla-
tion motif for c-Abl.
CAP localizes to focal adhesions, where it can bind vincu-
lin, FAK, paxillin and filamin C and to actin stress fibers,
which is probably, at least to some degree, mediated by
different sets of binding partners [1,7,8,27,28]. In fibrob-
lasts, overexpression of CAP has been described to slow
down the spreading of cells onto extracellular matrix [8].
However, according to our data, CAP does neither inhibit
nor enhance the spreading of epithelial cells onto
fibronectin. This could be explained by the differences in
the modes of regulation of focal adhesions and cell
spreading between different cell types or by the presence
of binding partners of CAP in fibroblasts that result in
inhibitory effects. Although c-Abl is an important regula-
tor of cytoskeletal remodeling and many of its substrates
are known to participate in the coordination of actin-
dependent processes, we could not observe any effect on
cell spreading when Y360, the major c-Abl phoshoryla-
tion site of CAP, or Y632 were mutated to Phe. Both
mutants were also localized in both focal adhesions and
stress fibers in a very similar way to the WT CAP protein.
The Y632F mutant also exhibited some nuclear localiza-
tion which is at present difficult to explain. Although a
nuclear form of CAP, termed R85Fl [3], has been
described, the isoform used here does not contain the
nuclear localization signal shown to mediate the nuclear
transport of R85Fl. Thus, the nuclear translocation of
Y632F mutant might be mediated by its interaction with
another protein that is capable of being transported into
the nucleus, as has been shown the case with teneurin-1
and CAP [29].
Since substitution of the major Abl phosphorylation sites
in CAP resulted in normal spreading of the cells, phos-
phorylation of CAP by c-Abl does not seem to play a
major role in this process. However, the mutation of Y326
slowed down the spreading, indicating that phosphoryla-
tion of this Tyr by another kinase might be important for
the regulation of CAP function during cell spreading.
Indeed, we could show that Y326 is phosphorylated by c-
Src, another non-receptor Tyr kinase that regulates many
actin dependent cellular processes, including focal adhe-
sion assembly and spreading [30,31]. If phosphorylation
of Y326 by c-Src indeed plays a role in the regulation of
cell spreading by CAP still needs to be clarified in more
detail in future studies.
As with Abl, the binding and phosphorylation of CAP by
Src was severely compromized by deletion of the C-termi-
nal SH3 region but not by mutations in the critical Trp res-
idued in the SH3 domains of CAP. Thus, also in the case
of Src, the linker regions between the SH3 domains and
the Pro rich sequences might mediate the interaction
between the kinase and its substrate. The main phospho-
rylation sites Y326 and Y360 do not reside in the SH3
region but more N-terminally to it, and thus the reduced
phosphorylation of ΔSH3 CAP by Src and Abl is unlikely
to be simply due to deletion of phosphorylatable Tyr res-
Phosphorylation of CAP in SYF cells can be rescued upon  expression of active forms of Src Figure 7
Phosphorylation of CAP in SYF cells can be rescued 
upon expression of active forms of Src. Embryonic 
fibroblasts from the triple knock-out mouse for Src, Yes and 
Fyn (SYF cells) were transfected with CAP-EGFP together 
with various forms of Src kinase and stimulated with vanad-
ate. No Tyr phosphorylation of CAP could be detected in 
cells expressing only CAP-EGFP or the inactive Src (Dead-
Src). Phosphorylation of CAP was rescued upon coexpres-
sion of either c-Src or the constitutively active mutant 
Y527F-Src.BMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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Tyr326 and Tyr360 are the major phosphorylation sites of Src Figure 8
Tyr326 and Tyr360 are the major phosphorylation sites of Src. A: CAP-EGFP and its mutant variants were transfected 
into HeLa cells together with c-Src and the phosphorylation of CAP was analyzed after immunoprecipitation. Tyr phosphoryla-
tion of the Y326F and Y360F mutant was reduced as compared to the WT CAP. An even lower level of phosphorylation could 
be detected for the Y326F+Y360F mutant. B: Quantification of the phosphorylation of CAP upon c-Src copexpression. Shown 
is the summary of the results of four independent experiments, error bars show standard deviation. C: c-Abl or c-Src was 
transfected into HeLa cells together with CAP-EGFP or EGFP, and the cells were treated with the Src inhibitor PP2, which 
does not inhibit Abl kinase at this concentration, or with non-inhibiting analogue PP3. In c-Abl transfected cells, inhibition of 
Src activity results in reduced phosphorylation of CAP, whereas in c-Src transfected cells, no phosphorylation could be 
detected after PP2 treatment.BMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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idues. In addition, mutation of six tyrosines within the
SH3 domain region of CAP (Y527, Y587, Y592, Y632,
Y678 and Y638) which all fit well to the consensus phos-
phorylation sequence of Src did not affect the phosphor-
ylation of CAP by c-Src (our unpublished data). Thus, the
SH3 region is more likely to be important for the sub-
strate-kinase interaction rather than providing substrate
tyrosines.
Substitution of Y360, the major Abl phosphorylation site,
alone only moderately impaired the phosphorylation of
CAP by Src. However, the double mutant Y326F/Y360F
showed a severely impaired phosphorylation by both Src
and Abl, implicating that both kinases might actually
cooperate to achieve the full degree of phosphorylation of
CAP. It could be speculated that Src plays only an indirect
role in the phosphorylation of CAP by facilitating Abl acti-
vation and thus increasing Abl-mediated CAP phosphor-
ylation. However, our in vitro phosphorylation assay with
purified proteins showed that CAP is a direct substrate of
Src. Furthermore, CAP interacted with Src in coimmuno-
precipitation experiments, and Y326 fits well to the con-
sensus phosphorylation sequence of c-Src. Thus, it
appears that both c-Src and c-Abl are capable of directly
phosphorylating tyrosines 326 and 360 in CAP, but each
show a preference to a different Tyr. However, inhibition
of Src activity in cells expressing c-Abl resulted in slightly
reduced phoshorylation of CAP. Thus, both kinases
appear to contribute to the phosphorylation and thereby
generate binding sites for SH2-containing proteins which
would link CAP downstream towards processes resulting
in actin remodeling. The details of the interplay between
Src and Abl in the phosphorylation of CAP should be clar-
ified in future studies in order to understand the role of
phosphorylation in the regulation of the function of CAP.
Conclusion
Taken together, our results show that CAP is a direct sub-
strate of both c-Abl and Src kinase which each phosphor-
ylate CAP at least in one Tyr residue. However, both
kinases appear to have their preferential phosphorylation
sites in CAP. The details of the functional regulation of
CAP by Abl- and Src-mediated phosphorylation still need
to be clarified in future studies. The SoHo proteins show
a very similar localization pattern, share many binding
partners and are all phosphorylated by c-Abl. So far, the
details of the functional significance of Abl-mediated
phosphorylation have not been characterized for any of
the SoHo proteins. Thus, it will be important to address
the specific downstream events that result from the phos-
phorylation of each of the SoHo family members and
which thus mediate the functional differences between
these proteins. Further work will also show how phospho-
rylation of CAP by Abl and Src contributes to its function.
Methods
Antibodies
Antibodies were as follows: immunoprecipitation: poly-
clonal anti-CAP (Biomol); polyclonal anti-GFP (Clon-
tech); Western blot: monoclonal anti-GFP (Roche);
monoclonal anti-c-Abl (Sigma); monoclonal anti-Src
(Upstate), monoclonal anti-phospho-Tyr (P-Tyr-100, Cell
Signaling); immunofluorescence: monoclonal anti-vincu-
lin (Sigma).
Plasmid cloning and mutagenesis
The isoform CAP1 (GeneBank U58883) containing a
SoHo domain and three C-terminal SH3 domains was
used in this study. CAP-EGFP was PCR amplified from
CAP-Flag (kind gift of A. Saltiel, Michigan, USA) and
cloned into the pEGFP-C1 vector (Clontech). CAP-EGFP
was used as a template to create the CAPΔSH3-EGFP con-
struct. Point mutations (W to F; Y to F) were generated
with QuikChange Site-Directed Mutagenesis Kit (Strata-
gene). The c-Abl and c-Src constructs were a kind gift of I.
Dikic (Frankfurt am Main, Germany).
Cell culture and transfection
Hep3B, SYF (ATCC: CRL-2459) and HeLa cells were cul-
tured in Dulbecco's modified Eagle's medium supple-
mented with 10% fetal calf serum. Transfections were
performed with Metafectene (Biontex, Munich, Ger-
many). Assays were performed 24-48 h post-transfection.
Insulin stimulation, Src inhibitor treatment and 
immunoprecipitation
Hep3B cells were pretreated with 100 nM insulin for 5
min or with 100 μM sodium ortho-vanadate for 30 min.
In some experiments (as marked in figures), transfected
HeLa cells were pretreated with 100 μM ortho-vanadate
for 25 min to induce phosphorylation. Src inhibition was
accomplished by incubating the cells with 5 μM PP1, PP2
or PP3 (Calbiochem) for 25 min. For detection of phos-
phorylated proteins, cells were lyzed in lysis buffer (100
mM Tris pH 8.0, 150 mM NaCl, 1 mM MgCl2, 1% Triton
X-100, 60 mM n-Octylglucoside), supplemented with
Protease Inhibitor Cocktail (Sigma) and 1 mM vanadate.
Lysates were incubated at 4°C for 16 h with Protein A
Dynabeads (Invitrogen) precoupled with the antibody.
Beads were washed with lysis buffer and PBS. The precip-
itated proteins were solubilized into 1× loading buffer by
incubation at 90°C for 3 min. Proteins were separated by
SDS-PAGE and subjected to immunoblotting with specific
antibodies.
Coimmunoprecipitation
Cells were lysed in coimmunoprecipitation buffer (50
mM Tris pH 7.6, 150 mM NaCl, 2 mM EDTA, 1% NP-40),
supplemented with Protease Inhibitor Cocktail (Sigma).BMC Cell Biology 2009, 10:80 http://www.biomedcentral.com/1471-2121/10/80
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The lysates were precleared with 3× 50 μl Pansorbin beads
(Calbiochem). After immunoprecipitation (see above),
the Dynabeads were washed six times with TBST (10 mM
Tris pH 8.0, 100 mM NaCl, 0.05% Tween 20) and once
with 0.1× PBS. Otherwise the samples were processed as
described above.
In vitro phosphorylation assay
25 ng of recombinant, purified GST fusion protein was
incubated in kinase buffer (10 mM Hepes pH 7.4, 5 mM
MgCl2, 0,2 mM EDTA) with 50 ng recombinant, active
human c-Src kinase (PHO3134, Biosource, Karlsruhe,
Germany) and 1 μCi [γ-32P]-ATP (2 mM) in a total volume
of 50 μl. After 15 min at 30°C, the reaction was stopped
by adding 15 μl loading buffer, and the samples were
denatured by incubating at 90°C for 3 min. Thereafter,
the samples were run on SDS-PAGE, the gel was fixed in
25% isopropanol/10% acetic acid and dried. The samples
were visualized by means of autoradiography on X-ray
films.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde for 20 min,
permeabilized with 50 μg/ml digitonin, blocked with 1%
bovine serum albumin in PBS, followed by labeling with
a primary antibody and a secondary Cy5-conjugated anti-
body. Actin cytoskeleton was stained with AlexaFluor594-
Phalloidin (Molecular Probes). Cells were embedded in
Gel/Mount (Biomeda) with 50 mg/ml 1,4-diazabicy-
clo(2,2,2)octane. Images were taken with a confocal laser-
scanning microscope (Zeiss LSM 510 Meta), exported and
processed with CorelDraw. Except for contrast and bright-
ness adjustment for some images, no other electronic
manipulations were undertaken. The images in Figure 4
represent single confocal slices of 1 μm thickness.
Cell spreading assay
Cell spreading assays were carried out as described before
[32], except that only 50.000 cells per well were seeded
out on fibronectin coated glass chambers. After 25 min of
spreading, the cells were washed, fixed and embedded as
above. The spreading status of cells was scored using a flu-
orescence microscope. The cells were divided into three
categories: non-spread (round but attached, no filopo-
dia), half-spread (roundish, filopodia-like protrusions)
and fully spread (flat, no filopodia-like protrusions,
prominent lamellipodial structures). For images of cells
representing each category, see [32].
Quantification and statistical analysis
Unless otherwise stated, all experiments were performed
at least three times. Quantification in Figs. 3 and 8 was
done densitometrically. The signals for phosphorylation
were corrected with the total amount of the respective
CAP variant and expressed as % of the signal observed for
the WT CAP which was defined as 100%. Results shown
represent the mean of values plus standard deviation. Sta-
tistical analysis was done using one way ANOVA (Bonfer-
roni test). * p < 0.05; ** p > 0.01
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